Macroeconomic data, vaccination, global trends to dictate markets: Analysts

Macroeconomic data, the pace of vaccination and global trends would be the major drivers for the domestic equity markets this week, analysts said.

stocks, markets, funds, growth, investments
Press Trust of India New Delhi
2 min read Last Updated : Jun 27 2021 | 11:37 AM IST

Macroeconomic data, the pace of vaccination and global trends would be the major drivers for the domestic equity markets this week, analysts said.

Besides, the progress of monsoon will also be monitored.

"This week marks the beginning of the new month also, so participants will be eyeing the high-frequency indicators like auto sales and manufacturing PMI during the week. Besides, the progress of monsoon will also remain on their radar.

"While the pace of vaccination drive is certainly encouraging as it gives hope of further unlocking by the states, the cases of new COVID variant might derail the plans," said Ajit Mishra, VP Research, Religare Broking.

"This week, the market is expected to continue its focus on global events as the domestic market lacks key triggers. Manufacturing PMI data is the major domestic economic data awaiting its release this week," Vinod Nair, Head of Research at Geojit Financial Services said.

Market participants would also monitor the movement of Brent crude, investment pattern of foreign institutional investors and the rupee.

Nirali Shah, Head of Equity Research, Samco Securities said, "Domestic indices are expected to mirror global equities. June auto sales numbers would give investors a fair idea around the revival of ground-level sentiment."

"Investors will be watching the progress on daily caseload, vaccination ramp-up and monsoon progress in the near term," said Binod Modi, Head Strategy at Reliance Securities.

During the last week, the 30-share BSE benchmark gained 580.59 points or 1.10 per cent.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirusstock marketsCoronavirus Vaccine

First Published: Jun 27 2021 | 11:37 AM IST

Next Story